These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7266955)

  • 1. Increased risk of malignant transformation of hydatidiform moles in older gravidas: a cytogenetic study.
    Tsuji K; Yagi S; Nakano R
    Obstet Gynecol; 1981 Sep; 58(3):351-5. PubMed ID: 7266955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant potential of gestational trophoblastic disease at the extreme ages of reproductive life.
    Bandy LC; Clarke-Pearson DL; Hammond CB
    Obstet Gynecol; 1984 Sep; 64(3):395-9. PubMed ID: 6087230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric and clinicopathologic study of complete hydatidiform moles with special reference to the significance of cytometric aneuploidy.
    Fukunaga M
    Gynecol Oncol; 2001 Apr; 81(1):67-70. PubMed ID: 11277652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New concepts and questions in gestational trophoblastic disease.
    Dodson MG
    J Reprod Med; 1983 Nov; 28(11):741-9. PubMed ID: 6361252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydatidiform molar pregnancy in Malaysian women: a histopathological study from the University Hospital, Kuala Lumpur.
    Cheah PL; Looi LM; Sivanesaratnam V
    Malays J Pathol; 1993 Jun; 15(1):59-63. PubMed ID: 8277792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
    Cui JQ; Shi YF; Zhou HJ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mitotic regime of benign and malignant tumors of the trophoblast].
    Pozharisskiĭ KM; Zueva EE; Semenovskiĭ AV
    Vopr Onkol; 1988; 34(6):689-94. PubMed ID: 3394268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric and clinicopathologic study of 197 hydatidiform moles with special reference to the significance of cytometric aneuploidy and literature review.
    Fukunaga M; Endo Y; Ushigome S
    Cytometry; 1995 Jun; 22(2):135-8. PubMed ID: 7587744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence of hydatidiform mole and aging of mothers (author's transl)].
    Honda J; Yanagida K; Sato E; Sugawara N; Munakata S; Fukushima T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jul; 34(7):915-9. PubMed ID: 7108309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analysis of cellular DNA and RNA contents of hydatidiform mole. Two significant parameters indicating malignant nature and prognosis.
    Yin GP; Su YK
    Chin Med J (Engl); 1993 Feb; 106(2):136-40. PubMed ID: 8389273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantitative analysis of the cellular DNA and RNA contents of hydatidiform mole and its clinical significance].
    Yin GP; Su YK; Zhuang GX
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):538-41, 574. PubMed ID: 7835131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of hydatidiform mole and choriocarcinoma.
    Bracken MB; Brinton LA; Hayashi K
    Epidemiol Rev; 1984; 6():52-75. PubMed ID: 6386504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant trophoblastic disorders. Epidemiologic aspects and relationship to hydatidiform mole.
    Matalon M; Paz B; Modan M; Modan B
    Am J Obstet Gynecol; 1972 Jan; 112(1):101-6. PubMed ID: 4332355
    [No Abstract]   [Full Text] [Related]  

  • 16. [On interrupted postmolar choriocarcinoma].
    Hando T; Kodama S; Takeuchi S; Goto S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2019-22. PubMed ID: 4078405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
    Persaud V; Ganjei P; Nadji M
    West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
    Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
    BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant potential of homozygous and heterozygous complete moles.
    Wake N; Seki T; Fujita H; Okubo H; Sakai K; Okuyama K; Hayashi H; Shiina Y; Sato H; Kuroda M
    Cancer Res; 1984 Mar; 44(3):1226-30. PubMed ID: 6318983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of the novel hydatidiform mole-related gene F10 with the invasiveness of trophoblastic tumor].
    Zhou J; Chen SL; Xing FQ; Pang ZJ; Li B; Zhou WQ; Fu X; Ding YQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):171-3. PubMed ID: 15698997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.